Indian version of Futibatinib price and channels

Futibatinib is a targeted drug used to treat cholangiocarcinoma (CCA), especially patients with intrahepatic cholangiocarcinoma who have FGFR2 gene fusions or other rearrangements. Although the original drug of fobatinib has been approved in multiple international markets, there is currently no locally produced original drug or generic version of fobartinib on the market in India.

Forbatinib’s original drug has been launched in international markets, especially Japan. Taking Japan as an example, the specification of forbatinib is usually 4mg*35 tablets, and the price is about 30,000 yuan. Sales of such brand-name drugs in overseas markets, especially in developing countries, are often more expensive, which may put some patients at risk of financial burden. However, the therapeutic effect of forbatinib may be an effective treatment option for those patients with advanced cholangiocarcinoma who have FGFR2 gene mutations.

In addition, generic drugs of forbatinib are already on the market in some countries, such as those produced in Laos. The price of the Lao version of forbatinib is significantly lower than that of the original drug. A drug of 4mg*35 tablets sells for about 2,500 yuan, which makes some patients with poor economic conditions affordable to receive drug treatment. It is worth noting that although the price of generic drugs is relatively low, their drug ingredients are basically the same as the original drugs, and their effects are relatively reliable, so they have become the choice of some patients.

However, forbatinib is not currently available in India, either as an original drug or a generic drug, so this drug is temporarily unavailable in the Indian market. If patients want to use forbatinib, they may need to rely on imported drugs or choose other treatment options to deal with cholangiocarcinoma. For example, they need to purchase through international drug procurement channels or through drug purchase platforms, but this may involve higher costs and complicated purchase procedures.

Reference materials:https://www.lytgobi.com/